Skip to content

Drug interactions

Enzalutamide + Ixazomib

Severity: Major

Enzalutamide and Ixazomib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Strong CYP3A inducers substantially reduce ixazomib exposure, as shown in pharmacokinetic studies with rifampin. This can lead to loss of efficacy.

What this interaction means in plain words

Enzalutamide and Ixazomib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Enzalutamide belongs to Endocrine; Ixazomib belongs to Oncology.

Evidence level: High

Why it happens

Enzalutamide induces CYP3A4, increasing ixazomib metabolism.

What to do

Avoid coadministration with strong CYP3A inducers as per labeling. Consider an alternative to enzalutamide.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Enzalutamide and Ixazomib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Enzalutamide with Ixazomib?

MediHelp rates the interaction as major. Enzalutamide and Ixazomib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Strong CYP3A inducers substantially reduce ixazomib exposure, as shown in pharmacokinetic studies with rifampin. This can lead to loss of efficacy.

How serious is the interaction between Enzalutamide and Ixazomib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid coadministration with strong CYP3A inducers as per labeling. Consider an alternative to enzalutamide.

What other medicines interact with Enzalutamide?

MediHelp also lists interactions of Enzalutamide with, for example, Doravirine, Elbasvir / grazoprevir, Ensitrelvir. The full list is on the Enzalutamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in